Richard H. Booth, Director at Adamas Pharmaceuticals Inc (ADMS), sold 2,000 shares at $17.51 ($35K) on 2014-12-24, disclosed to the SEC on 2014-12-29.
Scheduled sale ($35k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ADMS | SELL | 2015-04-16 | $18K | — | Filing → |
| ADMS | SELL | 2015-03-17 | $17K | — | Filing → |
| ADMS | SELL | 2015-02-18 | $17K | — | Filing → |